MKI67 and neoplasm: In particular, for breast cancer, many studies have investigated the expression of Ki-67 and suggested it as a prognostic and predictive marker (27, 28); its decreased expression has been associated with the reduction of tumor growth and efficacy of anticancer treatment (26, 28), which was already seen in our experiments.